MedTrace Logo

The Impact of Surgeon-Interpreted Intraoperative Margin Assessment During Breast Conserving Surgery on Postoperative Treatment

NCT07140965 · Status: SUSPENDED · Type: OBSERVATIONAL · Enrollment: 175

Last updated 2026-04-14

No results posted yet for this study

Summary

To learn if Pegulicianine Fluorescence-Guided Surgery (pFGS), which is part of the Lumicell Direct Visualization System, and Digital Breast Tomosynthesis (DBT) can improve the identification of tumor margins during a partial mastectomy and decrease the need for a second surgery.

Conditions

Interventions

PROCEDURE

Pegulicianine Fluorescence-Guided Surgery

Given by Surgery

PROCEDURE

Digital Breast Tomosynthesis

Given by Procedure

PROCEDURE

Breast Conserving Therapy

Given by Procedure

Sponsors & Collaborators

  • M.D. Anderson Cancer Center

    lead OTHER

Principal Investigators

  • Fedra Fallahian, MD · M.D. Anderson Cancer Center

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-10-09
Primary Completion
2027-09-30
Completion
2029-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07140965 on ClinicalTrials.gov